Page last updated: 2024-08-16

mitomycin and linezolid

mitomycin has been researched along with linezolid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bock, M; Bruun, NE; Bundgaard, H; Christensen, JJ; Christiansen, U; Elming, H; Fosbøl, EL; Fuursted, K; Gill, S; Helweg-Larsen, J; Høfsten, DE; Høiby, N; Ihlemann, N; Iversen, K; Køber, L; Moser, C; Povlsen, JA; Pries-Heje, MM; Rosenvinge, FS; Schwartz, F; Torp-Pedersen, C; Tønder, N; Van Hasselt, JGC; Wang, H1

Reviews

1 review(s) available for mitomycin and linezolid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for mitomycin and linezolid

ArticleYear
Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis.
    The Journal of antimicrobial chemotherapy, 2023, Dec-01, Volume: 78, Issue:12

    Topics: Anti-Bacterial Agents; Endocarditis, Bacterial; Humans; Linezolid; Mitomycin; Rifampin

2023